Vytrus Biotech (XMAD:VYT) OCF Margin %: 53.88% (As of Dec. 2025) — 93% Above Median


XMAD:VYT Vytrus Biotech SA XMAD:VYT
69 GF Score
Price €17.50
GF Value €5.54
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Vytrus Biotech OCF Margin %?

Vytrus Biotech XMAD:VYT +0.57% 69 OCF Margin % is 53.88% as of Dec. 2025, which is 93% above its 10-year median of 27.87. GuruFocus rates XMAD:VYT with a GF Score™ of 69/100 and a GF Value™ of €5.54 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 948 Biotechnology companies, Vytrus Biotech ranks better than 94.83% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Vytrus Biotech's Cash Flow from Operations for the six months ended in Dec. 2025 was €2.15 Mil. Vytrus Biotech's Revenue for the six months ended in Dec. 2025 was €3.99 Mil. Therefore, Vytrus Biotech's OCF Margin % for the quarter that ended in Dec. 2025 was 53.88%.

As of today, Vytrus Biotech's current OCF Yield % is 2.91%.

The historical rank and industry rank for Vytrus Biotech's OCF Margin % or its related term are showing as below:

XMAD:VYT' s OCF Margin % Range Over the Past 10 Years
Min: 15.98   Med: 27.87   Max: 46.58
Current: 46.58

During the past 8 years, the highest OCF Margin % of Vytrus Biotech was 46.58%. The lowest was 15.98%. And the median was 27.87%.

XMAD:VYT's OCF Margin % is ranked better than
94.83% of 948 companies
in the Biotechnology industry
Industry Median: -64.115 vs XMAD:VYT: 46.58

Vytrus Biotech OCF Margin % Related Terms

Vytrus Biotech OCF Margin % Historical Data

* Premium members only.

The historical data trend for Vytrus Biotech's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vytrus Biotech OCF Margin % Chart

Vytrus Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial 15.98 27.87 24.19 36.55 46.58

Vytrus Biotech Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.75 25.29 47.64 39.92 53.88

XMAD:VYT vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Vytrus Biotech's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vytrus Biotech OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vytrus Biotech's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Vytrus Biotech's OCF Margin % falls into.


XMAD:VYT
69GF Score
Vytrus Biotech SA XMAD:VYT
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vytrus Biotech OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Vytrus Biotech's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=3.9/8.372
=46.58 %

Vytrus Biotech's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=2.152/3.994
=53.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 53.88% mean?
Vytrus Biotech (XMAD:VYT) has a OCF Margin % of 53.88% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vytrus Biotech and its competitors. This is 93% above median its historical median of 27.87. Over the past decade, Vytrus Biotech's OCF Margin % has ranged from 15.98 to 46.58. According to the industry distribution chart, Vytrus Biotech ranks #49 out of 948 companies in the Biotechnology industry, placing it in the top 5.2%.
Is Vytrus Biotech's OCF Margin % too high?
Vytrus Biotech's current OCF Margin % of 53.88% is 93% above median its 10-year median of 27.87. Over the past 10 years, this metric has ranged from a low of 15.98 to a high of 46.58. Based on the distribution chart, Vytrus Biotech ranks #49 out of 948 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Vytrus Biotech has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vytrus Biotech's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vytrus Biotech ranks #49 out of 948 companies for OCF Margin %. This places Vytrus Biotech in the top 5% of its industry — outperforming the majority of peers. Historically, Vytrus Biotech's own OCF Margin % has ranged from 15.98 to 46.58 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vytrus Biotech and its competitors. Vytrus Biotech's current OCF Margin % is 53.88%, which is 93% above median its own 10-year median of 27.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vytrus Biotech stock overvalued right now?
Based on GuruFocus' analysis, Vytrus Biotech (XMAD:VYT) is currently considered Significantly Overvalued. The stock's GF Value™ is €5.54, compared to a current price of €17.50 — trading 215.9% above its estimated fair value. The current OCF Margin % is 53.88%, which is 93% above median its 10-year median of 27.87. Vytrus Biotech's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Vytrus Biotech (XMAD:VYT), the current OCF Margin % is 53.88% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vytrus Biotech (XMAD:VYT) Overvalued in 2026?

Based on GuruFocus' analysis, Vytrus Biotech stock appears to be overvalued. The current stock price of €17.50 is trading 215.9% above its estimated GF Value™ of €5.54. GuruFocus considers Vytrus Biotech to be Significantly Overvalued.

Key valuation signals for XMAD:VYT:

  • OCF Margin %: 53.88% (93% above median its 10-year median of 27.87)
  • GF Value™: €5.54 vs. price of €17.50 (215.9% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the XMAD:VYT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vytrus Biotech Business Description

Other Exchanges V5P:Germany
Address Sant Gaieta 121, 2nd Floor, Terrassa, Barcelona, ESP, 08221
Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.
69GF Score

Get the complete analysis for XMAD:VYT

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.50
Price
€5.54
GF Value